Age-related macular (AMD) degeneration is a leading cause of vision impairment and blindness in the elderly population.

Outlook Therapeutics has re-submitted its Biologics License Application (BLA) to the US Food and Drug Administration (FDA) ...

The data was included in the paper, titled “Sozinibercept Combination Therapy for Neovascular Age-Related Macular ...

Baseline angiographic lesion characteristics predictive of clinical responsePublished in peer-reviewed journal Ophthalmic Surgery, Lasers and ...

At the Envision Summit 2025 in San Juan, Puerto Rico, Giulia Corradetti, MD discussed AI applications in the identification ...

Wet AMD is the leading cause of vision loss in the elderly, affecting around three million people in the US and Europe and driving a retinal disease market that is worth upwards of $18 billion a year.

Apps may be available on your phone to help you monitor your wet AMD symptoms and assist you with everyday tasks such as reading, texting, and identifying objects. Advanced neovascular age-related ...

Wet AMD treatments can be costly ... It may also include coverage for tests like optical coherence tomography (OCT) and fluorescein angiography. Doctors use these tests to monitor disease ...

Optical coherence tomography (OCT): Uses imaging to ... to highlight abnormal blood vessels in the retina (used mainly for wet AMD diagnosis). While there is no cure for AMD, treatments can ...